Navigation Links
New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes
Date:11/21/2008

st-style-image: url(/images_v4/bullet_solid2.gif);">
  • INDICATIONS AND USAGE

    • Monotherapy and Combination Therapy

    • Important Limitations of Use

    • DOSAGE AND ADMINISTRATION

    • Recommended Dosing

    • Patients with Renal Insufficiency

    • Concomitant Use with a Sulfonylurea

    • DOSAGE FORMS AND STRENGTHS

    • CONTRAINDICATIONS

    • WARNINGS AND PRECAUTIONS

    • Use in Patients with Renal Insufficiency

    • Use with Medications Known to Cause Hypoglycemia

    • Hypersensitivity Reactions

    '/>"/>
    Source: PRWeb
    Copyright©2008 Vocus, Inc.
    All rights reserved  

    3

    GOOD

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

    Related medicine news :

    1. STAAR Surgical Forms Team of Leading Ophthalmic Surgeons to Study the Use of Collamer(R) Material for Accommodating Intraocular Lenses
    2. Landmark study defines benefits of early HIV testing and treatment for infected infants
    3. Study identifies causes of bone loss in breast cancer survivors
    4. New Study by BioTrends Highlights Practice Management Shifts Among Canadian Nephrologists
    5. Study Suggests Need for More Aggressive Outpatient Monitoring of Patients Hearts When Cause of Stroke is Unclear
    6. Rutgers researchers study cites media violence as critical risk factor for aggression
    7. Brigham and Womens Researchers Partner with Vocantas to use CallAssure in Clinical Research Study
    8. Analyst Available to Comment on New JUPITER Study That Shows AstraZenecas Crestor Significantly Reduces CV Risk
    9. New Study Finds CO2 Ablative Fractional Resurfacing Safe And Effective For Deep Acne Scarring
    10. Study investigates Gore-tex-type device to stop strokes and mini-strokes
    11. The smart way to study

    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    Related Image:
     New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 
    New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes
    (Date:12/3/2009)... Evaluation and Treatment Clinic...stock (Vocus) December 3, 2009 -- Centegra Health ...and H1N1 vaccine shots at four Centegra Primary Ca...ent of vaccine has arrived. The clinics are at CPC...enry and will be open as follows: ,   F...
    (Date:12/3/2009)... new findings, doubts linger about whether they ca...(HealthDay News) -- Whether cell phones cause brai... a new study confirms previous evidence suggesting...e incidents of brain tumors in Scandinavia found n... phone use became widespread, according to the rep...
    (Date:12/3/2009)... , LONDON, Dec. 3 Chiltern I... research organization (CRO) providing clinical de...ricas and Asia, today announces the appointment of...lobal Quality & Medical Affairs. Dr. Moore is .... ,, Dr. Moore is a physician with 15 years of ...
    (Date:12/3/2009)..., PHOENIX, Dec. 3 The day has co...he nation,s most prominent direct-care RN organiza...r the founding convention of the new 150,000-membe... professional association in U.S. history. ,, A...note address to the convention which will chart a ...
    (Date:12/3/2009)... , Recent CBO analysis understates key fact...ec. 3 A new actuarial a...nnual medical claims in the new individual market ... years after implementation of healthcare reform u...t (PPACA), excluding the impact of medical inflati...
    Breaking Medicine News(10 mins):Health News:Centegra H1N1 Vaccination Clinics Continue 2Health News:Centegra H1N1 Vaccination Clinics Continue 3Health News:Centegra H1N1 Vaccination Clinics Continue 4Health News:No Increase in Brain Tumors Seen From Cell Phones 2Health News:No Increase in Brain Tumors Seen From Cell Phones 3Health News:Chiltern Names Dr. Sharon Moore as Executive VP, Global Quality & Medical Affairs 2Health News:RN SuperUnion Founding Convention Opens Monday 2Health News:New Actuarial Analysis Shows Senate Bill Would Significantly Raise Premiums 2Health News:New Actuarial Analysis Shows Senate Bill Would Significantly Raise Premiums 3Health News:New Actuarial Analysis Shows Senate Bill Would Significantly Raise Premiums 4
    ...healthcare advisory services firm, announced today...s Karpook and Gregory Maddrey to the position of,P...ng healthcare,organizations in advancing their str...and Pam are senior advisors with vast industry,exp...
    ...ol Shootings, LOS ANGELES, March 5 On February 1...th shooter in the past,decade under the influence ...rug regulatory agencies to cause suicide, mania, p...ling 54,dead and 105 wounded, the mental health wa...
    ...at 8:00 am, the Bowen Foundation for Autism will h...s to raise money to fight autism. For a,registrati...tiful 5K,waterfront course complete with activitie...e awareness and resources for,the prevention, trea...
    ...in Your Teeth, VOORHEES, N.J., March 5 Federal t...imilar for 2007. Together with the,government,s ec...,200 or,more back in the pockets of most taxpayers...investment with that money. According to Dr. Jack ...
    ...duced at all NHS Hospital Trusts a study by resear...at smoking is still prevalent, even by staff in un...ealth Sciences conclude that effective enforcement...moking on site. , The study was carried out to d...
    ...ime reasons why, study finds , , WEDNESDAY...gers in automobiles that crash are more likely to ...ecially if the car is being driven by a young, ine...ers in this age group died in car crashes. , "We w...
    Other Medicine News:Health News:The Chartis Group Elects New Partners: Four Healthcare Industry Experts Promoted to Principal 2Health News:The Chartis Group Elects New Partners: Four Healthcare Industry Experts Promoted to Principal 3Health News:New Mini-Documentary Exposes Psychiatric Drugs Turning Kids into Killers 2Health News:New Mini-Documentary Exposes Psychiatric Drugs Turning Kids into Killers 3Health News:Inaugural Bowen Foundation Run/Walk to Fight Autism in Maryland Set for Saturday, March 29 2Health News:Smile When You Get that Refund 2Health News:Hospitals still not smoke-free 2Health News:Teen Passengers at Higher Death Risk in Car Crashes 2Health News:Teen Passengers at Higher Death Risk in Car Crashes 3
    (Date:12/3/2009)... HOERSHOLM, Denmark and SAN DIEGO, California, Dec...ssfully Inhibits miR-122, a microRNA Important for...tly Reducing Hepatitis C,Virus in the Bloodstream ...itis C Virus , - SPC3649 Demonstrates Eff...Serious Adverse Events in the Treated Animals - Si...
    (Date:12/3/2009)... Dec. 3 Cardium Therapeu...holly-owned subsidiary, Tissue Repair Company, sub... the U.S. Food and Drug Administration (FDA) seeki...duct candidate based on positive data from the Com... study. Today,s submission with the FDA covers Ex...
    (Date:12/3/2009)...alif., Dec. 3 Jazz Pharm...that Kathryn E. Falberg has been appointed Senior ...alberg brings to Jazz Pharmaceuticals more than 20...e. As Jazz Pharmaceutical,s CFO, Ms. Falberg will...orate finance, financial planning, investor relati...
    Breaking Medicine Technology:New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 2Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 4Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 5Weight Watchers 28R 29 Launches New Community on WeightWatchers com 55510 1Weight Watchers 28R 29 Launches New Community on WeightWatchers com 55510 2Weight Watchers 28R 29 Launches New Community on WeightWatchers com 55510 3Get Ready for Gruesome Cigarette Warnings 55508 1Get Ready for Gruesome Cigarette Warnings 55508 2Get Ready for Gruesome Cigarette Warnings 55508 3Mindray Medical to Participate in the SIG Third Annual Beijing Management Summit 55505 1Mindray Medical to Participate in the SIG Third Annual Beijing Management Summit 55505 2
    ...Form Medical,Inc. (Nasdaq: BFRM ) today announced...nded comparative study of nasolabial fold treatmen...Radiesse(R) dermal filler,than reported after trea...results of this study were published in the Decemb...c Surgery, a peer-reviewed publication of the,Amer...
    ...ent in Motor Function at 24 Months, SAN DIEGO, De...llow-up data from a Phase 1 clinical trial of CERE...ase. CERE-120 uses gene therapy to,deliver the neu...eurodegeneration that occurs in the brains of Park...ssments at 18 and 24 months post,treatment, sugges...
    Other Medicine Technology:Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 2Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 3Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 4Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 5Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 6Ceregene Presents Long-term Follow-up From Phase 1 Trial of CERE-120 in Parkinson's Disease 2Ceregene Presents Long-term Follow-up From Phase 1 Trial of CERE-120 in Parkinson's Disease 3Ceregene Presents Long-term Follow-up From Phase 1 Trial of CERE-120 in Parkinson's Disease 4
    Streck-Kleen Enzymatic Cleanser
    Streck-Diluent III Plus Balanced Electrolyte Solution
    Streck-CN free Lyse CD Lytic Reagent
    ...ted red blood cell (nRBC) control for evaluating t... 755 hematology analyzer in its enumeration of the...r LH 750/LH 755. nRBC-Chex for LH is a two-level c...nRBC-Chex for LH has a 75-day closed-vial stabilit...
    Medicine Products: